Dr. Caroline Popper, M.D. president and co-founder of Popper and Company, has 15 years of hands-on biotech/life sciences operating experience. Dr. Popper has business management experience in both Fortune 500 and start-up settings and extensive track record creating strategic and business partnerships in the biotech arena. Dr. Popper had a 10-year career at Becton Dickinson with global responsibilities included clinical affairs, marketing, strategy, and business development. Dr. Popper was the founding General Manager of BDGene. From 2000 to 2002, she was the Chief Business Officer for MDS Proteomics. Dr. Popper is currently a board member of ArrayExpress, Inc. Dr. Popper received her M.D. from the University of the Witwatersrand (South Africa) and her MPH from Johns Hopkins University (Baltimore).